v1
Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies.
Identifier:nobleid.org/w1/20260515/D9B2FE79
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/D9B2FE79)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims